Building on its legacy of innovations in drug delivery systems and treatments in Pain Management, Mundipharma is committed to direct its efforts in bringing to market innovative products to meet patient needs.
Mundipharma is one of the fastest growing pharmaceutical enterprises in the Emerging markets. This growth is supported by a heavy R&D focus on new product development that challenges orthodoxies to improve quality of life for people everywhere. Over its history of more than 60 years, Mundipharma has established its presence across six continents, with production facilities in US, UK, China, Canada, Germany and Cyprus
OUR COMMITMENT TO THE MEA REGION
We at Mundipharma are committed to serving patients in the MEA region, by identifying unmet needs and investing in bringing to market treatments that do not reach patients owing to the complexities in conducting business in this diverse yet interesting region. Mundipharma’s history of operating in the region for over 3 decades along with a leadership team that has spent significant time in the region, has allowed us to establish a solid network among all stakeholders in the healthcare system.
WHAT WE SEEK
Mundipharma is actively pursuing opportunities to
- Expand its current portfolio in Pain Management, Oncology, Respiratory, Consumer Healthcare and Ophthalmology.
- Expand into adjunct therapy areas where treatments are currently unavailable in the Middle East, Africa and Pakistan.